The GPR40 full agonist SCO-267 improves liver parameters in a mouse model of nonalcoholic fatty liver disease without affecting glucose or body weight
Ookawara, Mitsugi, Matsuda, Keisuke, Watanabe, Masanori, Moritoh, YusukeJournal:
Journal of Pharmacology and Experimental Therapeutics
DOI:
10.1124/jpet.120.000046
Date:
July, 2020
File:
PDF, 1.03 MB
2020